trial

An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia

NCTId NCT00996242
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 10 (actual)
Sponsored by Göteborg University
Primary completion 2008-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
10 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Single
Start
2007-09
Primary completion
2008-09
Eligibility
ALL · 23 Years · 56 Years

Interventions & indications

Drugs
L-lysine

Sponsors

Göteborg UniversityLead Sponsor
Stanley Medical Research InstituteCollaborator

Sites

1 total
Gothenburg, Sweden

Facts & assertions

4 sourced
Enrollment
10
Phase
NA
Primary Completion Date
2008-09
Status
COMPLETED
relationships
The graph out of here
drug
L-lysine
drug
lead_sponsor
Göteborg University
company
collaborator
Stanley Medical Research Institute
company
indication
Schizophrenia
indication
Schizophrenia
indication